Immune-Onc Therapeutics Stock

immune-onc.comHealthcareFounded: 2016Funding to Date: $143.15MM

Immune-Onc Therapeutics is a clinical-stage developer of novel biotherapeutics for cancer patients.

Register for Details

For more details on financing and valuation for Immune-Onc Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Immune-Onc Therapeutics.

Register Today

Other companies like Immune-Onc Therapeutics in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$1.08B
Sector